November 24, 2022
New authorization IMP (CAPSULES and BIOLOGICAL PRODUCTS)
Fulton received from AIFA a new authorization for the Investigational Medicinal Product (IMP) production of biological products in hard capsules.
Fulton is a pharmaceutical company that specialises in the research, development, formulation, manufacturing and packaging of pharmaceutical products.